Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting
DOI:
https://doi.org/10.2340/actadv.v103.4410Keywords:
hidradenitis suppurativa, prevalence, greenland, chronic disease, skin, questionnaireAbstract
Abstract is missing (Short communication)
Downloads
References
Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA 2017; 318: 2019-2032.
https://doi.org/10.1001/jama.2017.16691 DOI: https://doi.org/10.1001/jama.2017.16691
Kamil MAA, Chandran NS, Sulistyaningrum K, Rajagopalan M, Tahiliani S, Hsiao J, et al. The Asia Pacific Hidradenitis Suppurativa (APHiS) foundation: promoting hidradenitis suppurativa research in the Asia Pacific HHS Public Access. Int J Dermatol 2020; 59: 289-290.
https://doi.org/10.1111/ijd.14960 DOI: https://doi.org/10.1111/ijd.14960
Jemec GBE. Clinical practice. Hidradenitis suppurativa. New Engl J Med 2012; 366: 158-164.
https://doi.org/10.1056/NEJMcp1014163 DOI: https://doi.org/10.1056/NEJMcp1014163
Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619-644.
https://doi.org/10.1111/jdv.12966 DOI: https://doi.org/10.1111/jdv.12966
Krajewski PK, Matusiak Ł, von Stebut E, Schultheis M, Kirschner U, Nikolakis G, et al. Quality-of-life impairment among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients. Life 2021; 11: 34.
https://doi.org/10.3390/life11010034 DOI: https://doi.org/10.3390/life11010034
[Statistics G. Greenland in Numbers 2021; 3rd Edition][cited 2022 Jun 20]. Available from: www.stat.gl.
Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GBE. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 2014; 170: 884-889.
https://doi.org/10.1111/bjd.12787 DOI: https://doi.org/10.1111/bjd.12787
Sachdeva M, Shah M, Alavi A. Race-specific prevalence of hidradenitis suppurativa. J Cutan Med Surg 2021; 25: 177-187.
https://doi.org/10.1177/1203475420972348 DOI: https://doi.org/10.1177/1203475420972348
Hagan PG, Bouazzi D, Nyarko G, Dartey ES, Nunoo-Ghartey KB, Nkum D, et al. Prevalence of hidradenitis suppurativa in Berekum, Ghana. Br J Dermatol 2022; 187: 586-587.
https://doi.org/10.1111/bjd.21234 DOI: https://doi.org/10.1111/bjd.21234
Price KN, Hsiao JL, Shi VY. Race and ethnicity gaps in global hidradenitis suppurativa clinical trials. Dermatology 2021; 237: 97-102.
https://doi.org/10.1159/000504911 DOI: https://doi.org/10.1159/000504911
Lee DE, Clark AK, Shi VY. Hidradenitis suppurativa: disease burden and etiology in skin of color. Dermatology 2017; 233: 456-461.
https://doi.org/10.1159/000486741 DOI: https://doi.org/10.1159/000486741
Ahmad Kamil MA, Mohd Affandi A. Hidradenitis suppurativa in Kuala Lumpur, Malaysia: a 7-year retrospective review. Dermatol Res Pract 2018; 2018: 2017959.
https://doi.org/10.1155/2018/2017959 DOI: https://doi.org/10.1155/2018/2017959
Yang JH, Moon J, Kye YC, Kim KJ, Kim MN, Ro YS, et al. Demographic and clinical features of hidradenitis suppurativa in Korea. J Dermatol 2018; 45: 1389-1395.
https://doi.org/10.1111/1346-8138.14656 DOI: https://doi.org/10.1111/1346-8138.14656
Dauden E, Lazaro P, Aguilar MD, Blasco AJ, Suarez C, Marin I, et al. Recommendations for the management of comorbidity in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2018; 32: 129-144.
https://doi.org/10.1111/jdv.14517 DOI: https://doi.org/10.1111/jdv.14517
Bjerregaard P, Larsen CVL. Three lifestyle-related issues of major significance for public health among the Inuit in contemporary Greenland: a review of adverse childhood conditions, obesity, and smoking in a period of social transition. Public Health Rev 2018; 39: 5.
https://doi.org/10.1186/s40985-018-0085-8 DOI: https://doi.org/10.1186/s40985-018-0085-8
Published
How to Cite
License
Copyright (c) 2023 Sofia H.C. Botvid, Lone Storgaard Hove, Dorra Bouazzi, Rune Kjærsgaard Andersen, Simon Francis Thomsen, Ditte Marie Saunte, Gregor B.E. Jemec
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.